Quick Takeaways: Why It Matters? BiomEdit’s USDA conditional licensure for CPerf LLV (to be branded Optavant) creates the first genetically engineered probiotic biologic for poultry, offering a non‑antibiotic tool against necrotic enteritis-a disease costing the global broiler ...
Quick Takeaways: Why It Matters? BiomEdit’s new patents effectively lock up its engineered Lactobacillus reuteri pvAb platform, giving it composition‑of‑matter and methods‑of‑use protection around BE‑101 and future in situ biologic payloads delivered vi...
Quick Takeaways: Why It Matters? BE-101’s move into pivotal field safety testing brings the poultry sector closer to a commercially viable, non-antibiotic solution for necrotic enteritis, addressing a major economic and welfare burden while aligning with global pressure to...
